Post-Vaccination and Post-Infection Immunity to the Hepatitis B Virus and Circulation of Immune-Escape Variants in the Russian Federation 20 Years after the Start of Mass Vaccination.

HBV humoral immunity HBV immune escape variants HBV seroprevalence Hepatitis B epidemiology Hepatitis B vaccination Hepatitis B virus (HBV)

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
13 Feb 2023
Historique:
received: 14 12 2022
revised: 07 02 2023
accepted: 09 02 2023
entrez: 28 2 2023
pubmed: 1 3 2023
medline: 1 3 2023
Statut: epublish

Résumé

A neonatal vaccination against the Hepatitis B virus (HBV) infection was initiated in Russia 20 years ago, with catch-up immunization for adolescents and adults under the age of 60 years launched in 2006. Here, we have assessed the humoral immunity to HBV in different regions of Russia, as well as the infection frequency following 20 years of a nationwide vaccination campaign. We have also evaluated the role of immune-escape variants in continuing HBV circulation. A total of 36,149 healthy volunteers from nine regions spanning the Russian Federation from west to east were tested for HBV surface antigen (HBsAg), antibodies to HBV capsid protein (anti-HBc), and antibodies to HBsAg (anti-HBs). HBV sequences from 481 chronic Hepatitis B patients collected from 2018-2022 were analyzed for HBsAg immune-escape variants, compared with 205 sequences obtained prior to 2010. Overall, the HBsAg detection rate was 0.8%, with this level significantly exceeded only in one study region, the Republic of Dagestan (2.4%,

Identifiants

pubmed: 36851307
pii: vaccines11020430
doi: 10.3390/vaccines11020430
pmc: PMC9962567
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Russian Science Foundation
ID : ID-20-15-00148

Références

Vaccine. 2017 Aug 16;35(35 Pt B):4515-4522
pubmed: 28736196
J Med Virol. 2017 Dec;89(12):2130-2137
pubmed: 28543299
JAMA Netw Open. 2020 Nov 2;3(11):e2022388
pubmed: 33175174
Clin Liver Dis. 2016 Nov;20(4):607-628
pubmed: 27742003
Hepatology. 2020 Feb;71(2):431-443
pubmed: 31228279
J Gen Virol. 1992 Dec;73 ( Pt 12):3141-5
pubmed: 1469353
Viruses. 2022 Jul 11;14(7):
pubmed: 35891495
Caspian J Intern Med. 2011 Fall;2(4):289-98
pubmed: 24551434
Euro Surveill. 2009 Aug 13;14(32):
pubmed: 19679032
Intervirology. 2014;57(3-4):141-50
pubmed: 25034481
New Microbiol. 2022 May 10;45(4):
pubmed: 36066216
PLoS One. 2016 Jun 09;11(6):e0157161
pubmed: 27280884
Virus Res. 2019 Nov;273:197762
pubmed: 31541667
Infect Genet Evol. 2015 Jun;32:361-9
pubmed: 25784568
Vaccine. 2008 Nov 11;26(48):6064-7
pubmed: 18812198
J Infect Dis. 2003 Jan 1;187(1):134-8
pubmed: 12508157
Hepatol Int. 2021 Apr;15(2):328-337
pubmed: 33751394
PLoS One. 2022 Aug 22;17(8):e0272920
pubmed: 35994469
Vaccines (Basel). 2021 Jan 23;9(2):
pubmed: 33498794
World J Gastroenterol. 2016 Oct 21;22(39):8720-8734
pubmed: 27818588
Vaccine. 2013 Sep 13;31(40):4355-61
pubmed: 23887040
J Viral Hepat. 1997;4 Suppl 1:11-20
pubmed: 9097273
Arch Virol. 2018 Jun;163(6):1479-1488
pubmed: 29442226
Gastroenterology. 2007 Apr;132(4):1287-93
pubmed: 17433322
Drug Discov Ther. 2022 May 17;16(2):85-92
pubmed: 35491234
Hum Vaccin Immunother. 2022 Dec 30;18(7):2153535
pubmed: 36503415
Gut. 2004 Oct;53(10):1499-503
pubmed: 15361503
Clin Chim Acta. 2020 Nov;510:203-210
pubmed: 32679130
Vox Sang. 2004 Feb;86(2):83-91
pubmed: 15023176
PLoS One. 2011;6(9):e25130
pubmed: 21966434
Infect Disord Drug Targets. 2020;20(3):341-347
pubmed: 30277170
World J Hepatol. 2015 May 18;7(8):1086-96
pubmed: 26052397
Vaccine. 1996 Aug;14(11):1019-27
pubmed: 8879096
PLoS One. 2016 Jun 09;11(6):e0157103
pubmed: 27280441
J Clin Virol. 2013 Jul;57(3):201-8
pubmed: 22789139
J Biomed Sci. 2001 May-Jun;8(3):237-47
pubmed: 11385295
Vaccines (Basel). 2020 Aug 16;8(3):
pubmed: 32824318
BMC Infect Dis. 2022 May 12;22(1):452
pubmed: 35550023
J Gen Virol. 2020 Jun;101(6):571-572
pubmed: 32416744
N Engl J Med. 2011 Jan 20;364(3):236-47
pubmed: 21247314
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904
Methods Mol Med. 2004;95:115-24
pubmed: 14762301
J Med Virol. 2020 Feb 27;:
pubmed: 32104912
BMC Infect Dis. 2014 Jan 07;14:7
pubmed: 24397793

Auteurs

Fedor A Asadi Mobarkhan (FA)

Department of Socially Significant Viral Infections, Russian Medical Academy of Continuous Professional Education, 125993 Moscow, Russia.
Laboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia.

Victor A Manuylov (VA)

Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia.

Anastasia A Karlsen (AA)

Laboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia.
Scientific and Educational Resource Center for High-Performance Methods of Genomic Analysis, Peoples' Friendship University of Russia (RUDN University), 117198 Moscow, Russia.

Vera S Kichatova (VS)

Department of Socially Significant Viral Infections, Russian Medical Academy of Continuous Professional Education, 125993 Moscow, Russia.
Laboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia.

Ilya A Potemkin (IA)

Department of Socially Significant Viral Infections, Russian Medical Academy of Continuous Professional Education, 125993 Moscow, Russia.
Laboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia.

Maria A Lopatukhina (MA)

Laboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia.

Olga V Isaeva (OV)

Department of Socially Significant Viral Infections, Russian Medical Academy of Continuous Professional Education, 125993 Moscow, Russia.
Laboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia.

Eugeniy V Mullin (EV)

Laboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia.

Elena P Mazunina (EP)

Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia.

Evgeniia N Bykonia (EN)

Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia.

Denis A Kleymenov (DA)

Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia.

Liubov I Popova (LI)

Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia.

Vladimir A Gushchin (VA)

Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia.

Artem P Tkachuk (AP)

Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia.

Anna A Saryglar (AA)

Hospital of Infectious Diseases, 667003 Kyzyl, Russia.

Irina E Kravchenko (IE)

Department of Infectious Diseases, Kazan State Medical University of the Ministry of Healthcare of Russia, 420012 Kazan, Russia.

Snezhana S Sleptsova (SS)

Medical Institute, M.K. Ammosov North-Eastern Federal University, 677010 Yakutsk, Russia.

Victor V Romanenko (VV)

Medical Faculty, Ural State Medical University, 620014 Yekaterinburg, Russia.

Anna V Kuznetsova (AV)

Center for the Prevention and Control of AIDS and Infectious Diseases under Health Ministry of Khabarovsk Region, 680031 Khabarovsk, Russia.

Sergey A Solonin (SA)

N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Health Department, 129090 Moscow, Russia.

Tatyana A Semenenko (TA)

Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia.

Mikhail I Mikhailov (MI)

Department of Socially Significant Viral Infections, Russian Medical Academy of Continuous Professional Education, 125993 Moscow, Russia.
Laboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia.
Medical Faculty, Belgorod State National Research University, 308015 Belgorod, Russia.

Karen K Kyuregyan (KK)

Department of Socially Significant Viral Infections, Russian Medical Academy of Continuous Professional Education, 125993 Moscow, Russia.
Laboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia.
Scientific and Educational Resource Center for High-Performance Methods of Genomic Analysis, Peoples' Friendship University of Russia (RUDN University), 117198 Moscow, Russia.

Classifications MeSH